Diethylpropion in the Treatment of Obesity

نویسندگان

  • David R. Hadden
  • Conn Lucey
چکیده

DIETHYLPROPION ("Tenuate") has been shown to be useful in the treatment of refractory obesity (Seaton et al., 1961). Appetite suppression with the standard preparation is reported to last about four hours (Spielman, 1959) and the drug must be taken at least three times daily. This paper reports the use of a longacting preparation of the drug, which need be taken only once a day. It is marketed as "Tenuate Dospan" in which the active principle is incorporated with a hydrophilic colloid, which expands in the intestine and allows a continuous release of the drug. The advantage claimed, in addition to the virtual absence of undesirable central nervous stimulation (Wilson and Long, 1960; Nash, 1960), is that the sustained release tablet will provide hunger control for a full twelve hours. Diethylpropion (a-diethylaminopropionophenone) is closely related structurally to amphetamine (B-aminopropylbenzene).

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Efficacy of Long-term Obesity’s Treatment with Diethylpropion

Objective: To evaluate the efficacy and safety of long-term continuing treatment (24 months) of Diethylpropion (DEP) for weight loss in obese subjects. Research Methods and Procedures: A large, multicenter, randomized, placebocontrolled, dose-ranging trial in 3688 subjects demonstrated that DEP plus individualized nutritional intervention causes a dose-dependent decrease in body weight. The lon...

متن کامل

Update on pharmacology of obesity: benefits and risks.

The prevalence of obesity in Western countries has increased at a much greater pace than the development of new efficient and safe drugs, beyond mere lifestyle changes, for the treatment of overweight. Numerous different types of drugs which had been used in the past for the treatment of obesity have currently been withdrawn due to undesirable long-term side effects. The only available drug in ...

متن کامل

Appetite suppressants as adjuncts for weight loss.

Evidence-Based Answer Phentermine and diethylpropion are appetite suppressants approved for use in the United States as adjuncts in the treatment of obesity. These agents demonstrate a modest weight loss benefit when combined with dietary modifications and exercise. (Strength of Recommendation: B, based on a randomized trial and a meta-analysis.) No current evidence is available on the long-ter...

متن کامل

Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety.

To clarify the efficacy of antiobesity drugs, this article reviews all long-term (> or =36 weeks), placebo-controlled trials of obesity pharmacotherapy published since 1960. Since fears of anorexiant-induced heart valve damage preclude many physicians and patients from even considering antiobesity drugs, this area is also reviewed in-depth. Electronic database and manual bibliography search was...

متن کامل

Amphetamine-Like Analogues in Diabetes: Speeding towards Ketogenesis

Obesity is common in patients with type 1 and type 2 diabetes. Amphetamine-like analogues comprise the most popular class of weight loss medications. We present a case of a 34-year-old African American female with a history of type 1 diabetes, dyslipidemia, and obesity who developed diabetic ketoacidosis (DKA) after starting Diethylpropion for the purpose of weight loss. Shortly after starting ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Ulster Medical Journal

دوره 30  شماره 

صفحات  -

تاریخ انتشار 1961